Biosimilars And Follow-On Biologics Market - Forecast(2024 - 2030)

Report Code: HCR 80583 Report Format: PDF + Excel
1. Biosimilars And Follow-On Biologics Market - Overview
        1.1 Definitions and Scope
2. Biosimilars And Follow-On Biologics Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Biosimilars And Follow-On Biologics Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Biosimilars And Follow-On Biologics Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Biosimilars And Follow-On Biologics Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Biosimilars And Follow-On Biologics Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Biosimilars And Follow-On Biologics Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Biosimilars And Follow-On Biologics Market - By Manufacturing (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Segment Analysis
            8.3.1 In-House Manufacturing
            8.3.2 Contract Manufacturing Organization
9. Biosimilars And Follow-On Biologics Market - By Product (Market Size -$Million / $Billion)
        9.1 Erythropoetin
        9.2 Granulocyte-colony Stimulating Factor
        9.3 Growth Hormone
        9.4 Alfa Interferon
        9.5 Beta Interferon
        9.6 Monoclonal ANtibody
        9.7 Follitropin
10. Biosimilars And Follow-On Biologics - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Blood Disorder
            10.3.2 Cancer
            10.3.3 Chronic And Autoimmune Disease
            10.3.4 Growth Hormone Deficiency
11. Biosimilars And Follow-On Biologics- By Geography (Market Size -$Million / $Billion)
        11.1 Biosimilars And Follow-On Biologics Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Biosimilars And Follow-On Biologics- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Biosimilars And Follow-On Biologics- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Biosimilars And Follow-On Biologics - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong Kong
                  11.8.5.9 Rest of APAC
        11.9 Biosimilars And Follow-On Biologics - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Biosimilars And Follow-On Biologics Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Biosimilars And Follow-On Biologics Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Biosimilars And Follow-On Biologics Market - Key Company List by Country Premium
15. Biosimilars And Follow-On Biologics Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Biocon Limited
        15.3 Cadila Pharmaceutical
        15.4 Dr. Reddys Laboratory Limited
        15.5 F. Hoffmann-La Roche Ag
        15.6 Intas Pharmaceutical Limited
        15.7 Lupin Limited
        15.8 Reliance Life Science Private Limited
        15.9 Sanofi S A
        15.10 Torrent Pharmaceutical Ltd
        15.11 Wockhardt Limited
        15.12 Company 11
        15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Biosimilars And Follow-On Biologics Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Biosimilars And Follow-On Biologics Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
1.1 Erythropoetin Market 2023-2030 ($M) - Global Industry Research
1.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Global Industry Research
1.3 Growth Hormone Market 2023-2030 ($M) - Global Industry Research
1.4 Alfa Interferon Market 2023-2030 ($M) - Global Industry Research
1.5 Beta Interferon Market 2023-2030 ($M) - Global Industry Research
1.6 Monoclonal Antibody Market 2023-2030 ($M) - Global Industry Research
1.7 Follitropin Market 2023-2030 ($M) - Global Industry Research
2.Global India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
2.1 In-House Manufacturing Market 2023-2030 ($M) - Global Industry Research
2.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Global Industry Research
3.Global India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 (Volume/Units)
3.1 Erythropoetin Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Growth Hormone Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 Alfa Interferon Market 2023-2030 (Volume/Units) - Global Industry Research
3.5 Beta Interferon Market 2023-2030 (Volume/Units) - Global Industry Research
3.6 Monoclonal Antibody Market 2023-2030 (Volume/Units) - Global Industry Research
3.7 Follitropin Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 (Volume/Units)
4.1 In-House Manufacturing Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Contract Manufacturing Organization Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
5.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
5.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
5.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
5.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
5.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
5.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
5.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
6.North America India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
6.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
6.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
7.South America India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
7.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
7.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
7.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
7.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
7.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
7.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
7.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
8.South America India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
8.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
8.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
9.Europe India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
9.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
9.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
9.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
9.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
9.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
9.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
9.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
10.Europe India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
10.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
10.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
11.APAC India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
11.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
11.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
11.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
11.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
11.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
11.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
11.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
12.APAC India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
12.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
12.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
13.MENA India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
13.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
13.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
13.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
13.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
13.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
13.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
13.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
14.MENA India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
14.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
14.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
2.Canada India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
3.Mexico India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
4.Brazil India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
5.Argentina India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
6.Peru India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
7.Colombia India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
8.Chile India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
9.Rest of South America India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
10.UK India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
11.Germany India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
12.France India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
13.Italy India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
14.Spain India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
15.Rest of Europe India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
16.China India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
17.India India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
18.Japan India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
19.South Korea India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
20.South Africa India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
21.North America India Biosimilars And Follow-On Biologics By Application
22.South America India Biosimilars And Follow-On Biologics By Application
23.Europe India Biosimilars And Follow-On Biologics By Application
24.APAC India Biosimilars And Follow-On Biologics By Application
25.MENA India Biosimilars And Follow-On Biologics By Application
26.Cadila Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Lupin Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Torrent Pharmaceutical Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Sanofi S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Wockhardt Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Reliance Life Science Private Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Intas Pharmaceutical Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Dr. Reddys Laboratory Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Biocon Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)